These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


323 related items for PubMed ID: 28954263

  • 1. Beneficial Effects of High Doses of Cabergoline in the Treatment of Giant Prolactinoma Resistant to Dopamine Agonists: A Case Report with a 21-Year Follow-Up.
    de Castro LF, Magalhães Gonzaga MF, Naves LA, Luiz Mendonça J, Oton de Lima B, Casulari LA.
    Horm Res Paediatr; 2018; 89(1):63-70. PubMed ID: 28954263
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Secondary Resistance to dopamine agonist after thirteen months of successful treatment in a 42 years old man.
    Laboy-Ortiz IE, Velez-Maymí S, Hernán Martínez J, Trinidad R, Mangual M, Sanchez A, Gutierrez M, Mansilla P, Rivera C, Palermo C, de Lourdes Miranda M, Brau R.
    Bol Asoc Med P R; 2016; 108(1):31-36. PubMed ID: 29193928
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effectiveness of short-term maintenance treatment with cabergoline in microadenoma-related and idiopathic hyperprolactinemia.
    Buyukbayrak EE, Karageyim Karsidag AY, Kars B, Balcik O, Pirimoglu M, Unal O, Turan C.
    Arch Gynecol Obstet; 2010 Nov; 282(5):561-6. PubMed ID: 20571820
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of long-term cabergoline treatment for giant prolactinoma: study of 12 men.
    Shimon I, Benbassat C, Hadani M.
    Eur J Endocrinol; 2007 Feb; 156(2):225-31. PubMed ID: 17287412
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Women with prolactinomas presented at the postmenopausal period.
    Shimon I, Bronstein MD, Shapiro J, Tsvetov G, Benbassat C, Barkan A.
    Endocrine; 2014 Dec; 47(3):889-94. PubMed ID: 24711223
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A case of macroprolactinoma and elevated insulin-like growth factor-I in a young boy.
    Eyal O, Naffaa LN, Elder DA.
    Acta Paediatr; 2005 Dec; 94(12):1852-4. PubMed ID: 16421054
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.